Prevalence and risk factors associated with tardive dyskinesia among Indian patients with schizophrenia

Asian J Psychiatr. 2014 Jun:9:31-5. doi: 10.1016/j.ajp.2013.12.010. Epub 2014 Jan 4.

Abstract

Background: Tardive dyskinesia (TD) is one of the most distressing side effects of antipsychotic treatment. As prevalence studies of TD in Asian population are scarce, a cross-sectional study was performed to assess the frequency of TD in Indian patients with schizophrenia and risk factors of TD.

Method: Cross-sectional study of 160 Indian patients fulfilling the DSM-IV TR criteria for schizophrenia and who received antipsychotics for at least one year, were examined with two validated scales for TD. Logistic regression analyses were used to examine the relationship between TD and clinical risk factors.

Results: The frequency of probable TD in the total sample was 26.4%. The logistic regression yielded significant odds ratios between TD and age, intermittent treatment, and total cumulative antipsychotic dose. The difference of TD between SGA and FGA disappeared after adjusting for important co-variables in regression analysis.

Conclusion: Indian patients with schizophrenia and long-term antipsychotic treatment have a high risk of TD, and TD is associated with older age, intermittent antipsychotic treatment, and a high total cumulative antipsychotic dose. Our study findings suggest that there is no significant difference between SGAs with regards to the risk of causing TD as compared to FGAs.

Keywords: First generation antipsychotics; Prevalence; Risk factors; Second generation antipsychotics; Tardive dyskinesia.

MeSH terms

  • Adult
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use
  • Comorbidity
  • Cross-Sectional Studies
  • Dyskinesia, Drug-Induced / epidemiology*
  • Dyskinesia, Drug-Induced / etiology
  • Female
  • Humans
  • India / epidemiology
  • Male
  • Middle Aged
  • Prevalence
  • Risk Factors
  • Schizophrenia / drug therapy*
  • Schizophrenia / epidemiology
  • Young Adult

Substances

  • Antipsychotic Agents